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UbiquitinationRAS proteins conduct signaling from surface receptors to cytoplasmic
effectors, and RAS gain-of-function mutations are pervasive in cancer. A new
mechanism for RAS signal attenuationwith implications for receptor trafficking
has been uncovered.John Colicelli
RAS GTPases (HRAS, KRAS and
NRAS) function at the inner surface
of the plasma membrane to translate
receptor activation into cytoplasmic
signaling [1]. Following activation by
guanine nucleotide exchange factors
(GEFs), GTP-bound RAS proteins
transduce signals through multiple
downstream effector proteins with
the capacity to influence virtually
every aspect of cell biology.
GTPase-activating proteins (GAPs)
return RAS to the quiescent,
GDP-bound, state. Regulation of
RAS signaling is essential during
development, and loss-of-function
mutations in RAS, RAS-specific
GEFs/GAPs, or RAS effectors are
associated with a variety of
abnormalities. Cells in adult
organisms require tight control
of the same signaling pathways, and
gain-of-function mutations in RAS and
its effectors are pervasive in cancer.
In this issue of Current Biology, two
groups, using distinctly different
approaches, report a new pathway
for attenuation of RAS signaling [2,3].
They show that RABGEF1 (Rabex-5),
named for its role as a GEF and
activator of RAB5 GTPases during
endocytosis, functions as an E3
ubiquitin ligase that targets RAS
proteins to reduce downstream
signaling [2,3].
Mammalian HRAS and NRAS
proteins are post-translationally
palmitoylated and farnesylated [1],
promoting their localization to the
plasma membrane (the predominant
isoform of KRAS is farnesylated but
not palmitoylated, and its membrane
localization is regulated by a polybasic
motif and conditional phosphorylation
[4]). From their position on the plasma
membrane, RAS proteins effectively
transduce signals from receptortyrosine kinases, such as epidermal
growth factor receptor (EGFR), to
downstream effectors such as the
RAF–MEK–ERK kinase cascade
and other pathways. Mono- and
di-ubiquitination of HRAS and NRAS
is associated with their translocation
to endosomal membranes and
a concomitant reduction in ERK
activation, which is measured by dual
phosphorylation of ERK1 and ERK2 [5].
By contrast, KRAS is not ubiquitinated
and continues signaling through the
RAF–MEK–ERK pathway when
activated EGFR internalizes and traffics
to the late endosome [6].
In one of the new studies, the
Bar-Sagi group [2] considered
RABGEF1 (Rabex5), a known binding
partner of RAS proteins [7], to be
a strong candidate for promoting
HRAS and NRAS ubiquitination.
RABGEF1 contains an A20-type zinc
finger (ZnF-A20, IPR002653) domain
with E3 ubiquitin ligase activity and an
adjacent a helix with ubiquitin-binding
activity [8,9]. Indeed, ectopic
expression of RABGEF1 enhanced the
ubiquitination of HRAS and NRAS in
cultured mammalian cells, while
RABGEF1 silencing diminished HRAS
and NRAS ubiquitination [2].
Importantly, the capacity of RABGEF1
to promote RAS ubiquitination was
blocked by a mutation in the ZnF
domain but not by a mutation in the
GEF domain. RAS ubiquitination by
wild-type RABGEF1, but not the ZnF
mutant, was recapitulated in a cell-free
system to confirm target specificity.
The Pfleger group [3] began with the
observation that a Drosophila Rabex5
(RABGEF1 ortholog) loss-of-function
mutant has dramatic phenotypic
alterations, including ectopic
wing veins, melanotic tumors and
eye/antenna fate switching.
These phenotypes are strikingly similar
to those caused by a gain-of-functionmutation in Ras (Drosophila has
a single ortholog of mammalian HRAS,
NRAS and KRAS). This group also
showed that phenotypes resulting from
Rabex-5 silencing were suppressed
by a Ras loss-of-function mutation [3].
These inverse relationships suggested
that Rabex5 normally inhibits Ras
signaling in this system. Further,
the phenotypes of a Rabex5
loss-of-function mutant were rescued
by ectopic expression of a wild-type
or GEF domain mutant of Rabex5,
but not by a ZnF mutant of Rabex5.
This demonstrated that the Rabex5
ubiquitin ligase function, but not the
guanine nucleotide exchange function,
was responsible for Rabex5-mediated
regulation of Ras activity. In addition,
Drosophila Rabex5 was shown to
ubiquitinate Ras in an insect cell
culture system.
RABGEF1/Rabex5 gain-of-function
mutations resulted in a reduction in
downstream signaling by HRAS
and NRAS in mammalian cells and
by Drosophila Ras, as judged by
lower levels of dual phosphorylated
ERK proteins. Reinforcing this
interpretation, phenotypes caused
by a constitutively active Egfr
(which acts upstream of Ras) were
exacerbated by loss of Rabex5 in the
Drosophila system. These findings
shed light on a previous report [7],
which showed that silencing or loss
of mouse RABGEF1 increased RAS
activity and ERK phosphorylation
following stimulation of mast cell
immunoglobulin E receptors (Fc3RI).
The new findings suggest amechanism
for reducing ERK signaling after
receptor internalization, but leave
unresolved whether ubiquitinated and
endosome-localized RAS proteins
continue to signal through alternative
downstream effector pathways.
RAS ubiquitination is associated with
translocation to endosomemembranes
[5] and, consistent with this, RABGEF1
overexpression correlated with higher
levels of GFP-tagged HRAS on
EEA1-positive vesicles, while
RABGEF1 silencing diminished
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Figure 1. Model for RABGEF1-mediated RAS ubiquitination, with endosome localization and
reduced RAF–MEK–ERK signaling.
(A) Ligand binding and tyrosine phosphorylation of receptor tyrosine kinases (blue ball in green
cup/stick), such as EGFR, leads to RAS activation at the plasma membrane via adaptor and
RAS-GEF proteins (green arrows). GTP-loaded RAS signals through downstream effectors
including the RAF–MEK–ERK kinase cascade and the RIN1–RAB5 activation pathway. Active
GTP-bound RAB5 recruits its own effectors including RABEP (rabaptin) with associated RAB-
GEF1. The ZnF-A20 domain of RABGEF1 (ZnF) directs the addition of ubiquitin (Ub) to RAS. (B)
Endosomes carrying RTKs include ubiquitinated RAS, which becomes uncoupled from the
RAF–MEK–ERK pathway but may continue to signal through other effectors. RABGEF1 is
retained on endosomes, where it maintains high levels of active RAB5 to promote endosome
trafficking and fusion.
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[2]. It remains uncertain, however,
whether ubiquitination drives the
movement of HRAS and NRAS
to endosomes or whether this
modification is simply required to retain
RAS proteins that have already been
incorporated into endosomes during
receptor endocytosis.
Much about the choreography of
RAB5-driven endocytosis remains
unresolved. RAB5 family members
(RAB5A–C and the related proteins
RAB17, RAB21, RAB22, RAB31)
participate in the early stages of
endosome trafficking and fusion.
These GTPases depend on activation
by GEFs of the VPS9 family (RABGEF1,
GAPVD1, RIN1–3 and the related
proteins RINL, ALS2, ALS2CL,
ANKRD27, C16orf7). The functional
interaction of RAB5 proteins with
regulatory GEFs and effectors has
received much attention (reviewed in
[10]), and aRAB5endosome fusion cell-
free system using purified RABGEF1
has been described [11]. Much less is
understood about precisely where and
when RAB5 proteins are activated
(i.e. GTP loaded), or how this leads to
engagement of RAB5 effector proteins
(RABEP1–2, ZFYVE20, ANKFY1, EEA1
and MON1A–B).
The work of Xu and colleagues [2]
implicates a second exchange factor
in the pathway leading to RAS
ubiquitination. RIN1 is a RAS effector
[12,13] and a RAB5-directed GEF [14]
implicated in endocytosis.
Overexpression of RIN1 enhanced
HRAS ubiquitination, but this effect
was dependent on RABGEF1 and
therefore likely to reflect an event
occurring upstream of RABGEF1. And,
unlike RABGEF1, the GEF function of
RIN1 is required for enhancement of
HRASubiquitination. Of note, RIN1may
also participate in endocytosis through
a Src homology 2 (SH2) domain that
binds activated receptor tyrosine
kinases [15] and a domain that
activates ABL tyrosine kinase to
promote actin cytoskeleton
remodeling [16].
These findings suggest a possible
sequence of events following RAS
activation (for example, following
receptor tyrosine kinase stimulation;
Figure 1). Signaling through the
downstream effector RAF triggers MEK
and ERK activation, while the RAS
effector RIN1 converts GDP-bound
(inactive) RAB5 to GTP-bound (active)
RAB5. Once activated, RAB5 can thenengage its own effectors, including
RABEP (rabaptin) proteins. RABGEF1
may be recruited to the growing
complex by its early endosome
targeting domain [17] and through
associations with RABEP [18] and
RAB22 [19]. RABGEF1 then acts
through its ZnF-A20 domain as an E3
ligase for RAS ubiquitination, which
correlates with endosome localization
and diminished signaling through ERK
proteins. This process also leaves
RABGEF1 well positioned to function
through a feedback loop [20] to
maintain elevated levels of GTP-boundRAB5 proteins on the nascent
endosome.
Characterizing the role of RABGEF1
in RAS ubiquitination and endosome
localization represents a significant
advance in understanding RAS
signal regulation following receptor
stimulation and will invigorate
research in this area. Among the
questions raised by this work are
the timing of RAS ubiquitination
relative to endosome trafficking and
the identity of other ubiquitination
targets of RABGEF1. Also unclear is
the fate of ubiquitinated RAS: is it
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R632de-ubiquitinated for recycling to the
plasma membrane or sent to a
degradation pathway?References
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One of the mysteries of social evolution
is the emergence, in evolutionary
history, of close, enduring social
bonds in animal groups. Neither of
the two main proposed functions of
group living — the protection from
predation that comes with increased
numbers, or the increased access
to food that comes with shared
defense and knowledge of resources
[1–3] — obviously requires the
well-differentiated social bonds that
animals of many species, notably
primates, develop. Anyone who has
watched a group of primates for any
length of time has surely been struck by
the attention that animals in these
groups pay to distinguishing their close
associates — their ‘friends’ — from
others, and to nurturing their closebonds. What evolutionary forces have
shaped the pursuit of these bonds?
Joan Silk and her colleagues have
been digging into this question for
several years. In earlier work they
demonstrated, in two different
populations of baboons, that females
with stronger social bonds experience
higher survival of their infants [4,5].
Writing in this issue of Current Biology,
they have extended these results to
show that females with stronger and
more stable social bonds also
experience greater longevity
themselves (Figure 1) [6]. Moreover,
the effect of close, stable bonds is
independent of the effect of dominance
rank, which also contributed to
longevity in the study. Survival and
longevity are a major component of
Darwinian fitness — all else being
equal, individuals that live longerwill produce more offspring and
have higher fitness that those that
die young. Thus, this new study
provides a strong basis for inferring
natural selection on the development
and maintenance of close social
bonds.
This is a remarkable result, which
has some interesting and important
parallels in human biomedical
research. Research in the past several
decades has revealed striking
associations between loneliness and
social isolation on the one hand, and
health and wellness on the other.
Among the most robust of these is
a link between loneliness and survival
after heart attacks [7], but data on
a number of other health indicators
and physiological measures show
that people who experience social
isolation have poor health outcomes
in a number of contexts, as well as
elevated physiological indicators of
stress [6,8–10]. Social contact has
also been shown to have an
ameliorating effect on physiology in
a number of animals, including
laboratory rodents, monkeys, and
domestic companion animals [11,12].
